Form 4: Adaptive Biotechnologies CFO Tycho Peterson Reports Stock Transactions

Adaptive Biotechnologies' CFO, Tycho Peterson, reports the acquisition and disposition of company stock to cover tax obligations related to RSU vesting.

Summary

• On March 4, 2024, Tycho Peterson, CFO of Adaptive Biotechnologies, acquired 147,790 shares of common stock at $0.
• Following this acquisition, Peterson directly owned 547,009 shares.
• On March 5, 2024, Peterson disposed of 15,456 shares of common stock at a price of $3.44 per share.
• This disposal resulted in Peterson directly owning 531,553 shares.
• The sale of shares was to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs) and was mandated by the issuer's equity incentive plans.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock transactions by a company insider to cover tax obligations. It doesn't indicate any significant positive or negative sentiment.

Management Comments

• The sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but it is unlikely to be significant.

Key Dates